(Q48495966)

12 February 2018

title

Inflammation takes on Alzheimer disease. (English)

1 reference

12 February 2018

0 references

0 references

Todd E Golde

1

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 September 2002

1 reference

12 February 2018

published in

Nature Medicine

1 reference

12 February 2018

volume

8

1 reference

12 February 2018

issue

9

1 reference

12 February 2018

page(s)

936-938

1 reference

12 February 2018

https://scigraph.springernature.com/pub.10.1038/nm0902-936

exact match

0 references

cites work

Alzheimer's disease: genes, proteins, and therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-936

Inflammation and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-936

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-936

Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-936

Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-936

TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-936

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-936

Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-936

The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-936

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-936

Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-936

inferred from DOI database lookup

7 January 2021

based on heuristic

Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0902-936

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NM0902-936

1 reference

12 February 2018

1 reference

12 February 2018